Display options
Cite
Knight EA, Osunsuyi-Fagbemi S, Neely J. Managing Patients With Myelofibrosis in the Era of Janus Kinase Inhibitors. J Adv Pract Oncol. 2015;6(6):532-50
Knight, E. A., Osunsuyi-Fagbemi, S., & Neely, J. (2015). Managing Patients With Myelofibrosis in the Era of Janus Kinase Inhibitors. Journal of the advanced practitioner in oncology, 6(6), 532-50.
Knight, Emily A, et al. "Managing Patients With Myelofibrosis in the Era of Janus Kinase Inhibitors." Journal of the advanced practitioner in oncology vol. 6,6 (2015): 532-50.
Knight EA, Osunsuyi-Fagbemi S, Neely J. Managing Patients With Myelofibrosis in the Era of Janus Kinase Inhibitors. J Adv Pract Oncol. 2015 Nov-Dec;6(6):532-50. Epub 2015 Nov 01. PMID: 27648344; PMCID: PMC5017545.
Copy Download .nbib Format: NLM
Share it on

J Adv Pract Oncol. 2015 Nov-Dec;6(6):532-50. Epub 2015 Nov 01.

Managing Patients With Myelofibrosis in the Era of Janus Kinase Inhibitors.

Journal of the advanced practitioner in oncology

Emily A Knight, Sylvia Osunsuyi-Fagbemi, Jessica Neely

Affiliations

  1. 1Mayo Clinic, Scottsdale, Arizona; 2Winship Cancer Institute at Emory University, Atlanta, Georgia.

PMID: 27648344 PMCID: PMC5017545

[No abstract available.]

References

  1. Blood. 2012 Sep 27;120(13):2768-9 - PubMed
  2. Am J Hematol. 2012 Jan;87(1):66-8 - PubMed
  3. Leukemia. 2008 Feb;22(2):437-8 - PubMed
  4. Leukemia. 2014 Jan;28(1):225-7 - PubMed
  5. N Engl J Med. 2013 Dec 19;369(25):2379-90 - PubMed
  6. N Engl J Med. 2012 Mar 1;366(9):787-98 - PubMed
  7. Leuk Lymphoma. 2001 Sep-Oct;42(5):901-11 - PubMed
  8. Chest. 2013 May;143(5):1478-9 - PubMed
  9. Leukemia. 2013 Jun;27(6):1322-7 - PubMed
  10. Curr Hematol Malig Rep. 2014 Dec;9(4):350-9 - PubMed
  11. J Clin Oncol. 2011 Apr 1;29(10):1356-63 - PubMed
  12. Br J Haematol. 2013 Apr;161(1):68-75 - PubMed
  13. Blood. 2011 Jul 14;118(2):401-8 - PubMed
  14. Leuk Res. 2014 Sep;38(9):1126-9 - PubMed
  15. Cancer. 2007 Jan 1;109(1):68-76 - PubMed
  16. Blood. 2010 Mar 4;115(9):1703-8 - PubMed
  17. Leukemia. 2014 Jul;28(7):1486-93 - PubMed
  18. J Clin Oncol. 2011 Feb 20;29(6):761-70 - PubMed
  19. Leuk Res. 2011 Jan;35(1):12-3 - PubMed
  20. Leukemia. 2014 Feb;28(2):449-51 - PubMed
  21. Curr Opin Hematol. 2014 Mar;21(2):114-22 - PubMed
  22. Blood. 2014 Apr 3;123(14):2220-8 - PubMed
  23. Am J Hematol. 2014 Mar;89(3):344-6 - PubMed
  24. Wien Klin Wochenschr. 2013 Apr;125(7-8):196-9 - PubMed
  25. Haematologica. 2013 Dec;98(12):1865-71 - PubMed
  26. Clin Lymphoma Myeloma Leuk. 2013 Dec;13(6):638-45 - PubMed
  27. Int J Gen Med. 2014 Jan 29;7:89-101 - PubMed
  28. N Engl J Med. 2013 Dec 19;369(25):2391-405 - PubMed
  29. Blood. 2009 Mar 26;113(13):2895-901 - PubMed
  30. Blood. 2013 Dec 12;122(25):4047-53 - PubMed
  31. Leuk Res. 2013 Aug;37(8):911-6 - PubMed
  32. Br J Haematol. 2015 Apr;169(1):77-80 - PubMed
  33. Leukemia. 2013 Sep;27(9):1861-9 - PubMed
  34. Blood. 2009 Jul 30;114(5):937-51 - PubMed
  35. Hematology Am Soc Hematol Educ Program. 2011;2011:208-14 - PubMed
  36. Haematologica. 2015 Apr;100(4):479-88 - PubMed
  37. Cancer Med. 2013 Dec;2(6):889-98 - PubMed
  38. Eur Cytokine Netw. 2008 Jun;19(2):69-80 - PubMed
  39. Leuk Lymphoma. 2014 Mar;55(3):595-600 - PubMed
  40. J Hematol Oncol. 2013 Oct 29;6(1):81 - PubMed
  41. Onco Targets Ther. 2013 Dec 17;7:13-21 - PubMed
  42. Clin Lymphoma Myeloma Leuk. 2014 Dec;14(6):525-33 - PubMed
  43. N Engl J Med. 2013 Jul 11;369(2):197-8 - PubMed
  44. J Clin Oncol. 2012 Nov 20;30(33):4098-103 - PubMed
  45. Hematology Am Soc Hematol Educ Program. 2011;2011:222-30 - PubMed
  46. Blood. 2012 Aug 9;120(6):1202-9 - PubMed
  47. Br J Haematol. 2013 Jul;162(2):229-39 - PubMed
  48. Br J Haematol. 2013 Sep;162(6):783-91 - PubMed
  49. Blood. 2014 May 29;123(22):e123-33 - PubMed
  50. Med Oncol. 2014 Mar;31(3):869 - PubMed
  51. Blood. 2009 May 28;113(22):5394-400 - PubMed
  52. Blood. 2014 Jun 12;123(24):3803-10 - PubMed
  53. Blood. 2014 Mar 20;123(12):1833-5 - PubMed
  54. Leukemia. 2014 Aug;28(8):1750-1 - PubMed
  55. Blood. 2013 Aug 15;122(7):1192-202 - PubMed
  56. N Engl J Med. 2000 Apr 27;342(17):1255-65 - PubMed
  57. Leuk Lymphoma. 2013 Feb;54(2):242-51 - PubMed
  58. Blood. 2005 Feb 1;105(3):973-7 - PubMed
  59. Int J Oncol. 2005 Sep;27(3):855-60 - PubMed
  60. N Engl J Med. 2012 Mar 1;366(9):799-807 - PubMed
  61. Clin Lymphoma Myeloma Leuk. 2015 Apr;15(4):214-221.e1 - PubMed
  62. J Clin Oncol. 2013 Apr 1;31(10):1285-92 - PubMed
  63. Haematologica. 2014 Feb;99(2):292-8 - PubMed
  64. Blood. 2015 Apr 23;125(17 ):2649-55 - PubMed
  65. Cytokine Growth Factor Rev. 2013 Apr;24(2):133-45 - PubMed
  66. Eur Cytokine Netw. 2004 Oct-Dec;15(4):312-6 - PubMed
  67. Mod Pathol. 2012 Sep;25(9):1193-202 - PubMed
  68. J Clin Oncol. 2011 Feb 1;29(4):392-7 - PubMed
  69. Hematology Am Soc Hematol Educ Program. 2013;2013:545-52 - PubMed
  70. J Clin Oncol. 2007 Nov 10;25(32):5106-12 - PubMed
  71. Leukemia. 2014 Jul;28(7):1494-500 - PubMed
  72. Leuk Res. 2013 Nov;37(11):1440-4 - PubMed
  73. Br J Cancer. 1996 Jun;73(12):1560-2 - PubMed
  74. J Hematol Oncol. 2013 Oct 22;6:79 - PubMed
  75. Leuk Res. 2009 Sep;33(9):1199-203 - PubMed
  76. Semin Cell Dev Biol. 2008 Aug;19(4):385-93 - PubMed

Publication Types